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Introduction: Coronary artery ectasia is an uncommon disease that has been increasingly noticed as the increase in
utilization of coronary angiograms. The aim of this study is to characterize coronary artery ectasia in the population of
Saudi Arabia.
Methods: This is a retrospective study involved all patient with invasive coronary angiogram that was done at a
tertiary hospital in Saudi Arabia from January 2011 to December 2013.
Results: A total of 1115 coronary angiograms were reviewed. Coronary artery ectasia was found in 67 patients (6%
of all coronary angiograms). The right coronary artery was involved in 73% of cases. And 43% of the cases had severe
ectasia.
Conclusion: The prevalence of coronary artery ectasia in Saudi Arabia among patient who went for coronary
angiography is higher than what has been published in previous studies and a significant number of patients have
severe disease.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Coronary artery ectasia is an uncommon entitythat has been seen with increasing fre-
quency as the utilization of coronary angiograms
has expanded, facilitating the diagnosis and man-
agement of coronary artery disease. It is defined
as dilatation of a coronary artery segment to a
diameter at least 1.5 times that of the adjacent nor-
mal coronary artery [1–3]. Its first angiographicdescription was by Munkner et al. in 1958 [4],
but the original description of the disease by
Morgagni goes back to 1761 [5]. It has an estimated
incidence of 1–5% of all invasive coronary angio-
grams [3,6,7]. Coronary artery ectasia has been
attributed to atherosclerosis in about 50% of cases,
related to inflammatory and connective tissue dis-
ease in 10–20% of cases, and thought to be con-
genital in origin in 20–30% of ectasia cases [2,8,9].
The aim of this study is to characterize coronary
artery ectasia in the population of Saudi Arabia.
Table 1. Baseline characteristics and biochemical profile of
patients.
Patient characteristics N = 67
Age (years) 56 ± 12
Sex (male %) 82%
Nationality (Saudi %) 54%
Diabetes mellitus 59%
Hypertension 64%
Dyslipidemia 59%
Smoking 31%
Chronic renal failure 11%
Hemoglobin (g/dL) 13.2 ± 2.2
Glycosylated hemoglobin (%) 7.5 ± 2.1
Total cholesterol (mg/dL) 168 ± 46.8
LDL cholesterol (mg/dL) 100.5 ± 41.7
HDL cholesterol (mg/dL) 35.4 ± 12.2
Triglyceride (mg/dL) 152.9 ± 95.3
Serum creatinine (mg/dL) 1.3 ± 1.5
Ejection fraction (%) 53.4 ± 15.5
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This is a retrospective study including all
patients who underwent invasive coronary angio-
grams in a tertiary hospital in Saudi Arabia from
January 2011 to December 2013. The data was col-
lected from medical records and hospital data-
bases. An interventional cardiologist reviewed all
angiograms, and ectasia was recognized when a
dilated segment of a coronary artery had a diame-
ter at least 1.5 times that of adjacent coronary seg-
ment. Coronary ectasia was classified based on
the extent of the disease, according to the proposal
by Markis et al [10]. Diffuse ectasia involving two
or three vessels was classified as type I; diffuse
disease in one vessel and localized disease in
another vessel as type II; diffuse ectasia in one
vessel only as type III; and localized ectasia as
type IV. Obstructive coronary artery disease was
defined as 50% or more diameter stenosis in the
left main coronary artery or 70% or more diameter
stenosis in a major coronary artery [11]. Slow flow
was defined as sluggish clearing of the coronary
artery, that is, when the vessel fills completely
but either fills or empties slower than uninvolved
vessels in the absence of coronary obstruction [12].
The hospital institutional review board
approved the study protocol. The data was ana-
lyzed and the baseline characteristics were com-
puted using mean and standard deviation for
continuous variables and percentage for dichoto-
mous variables.Figure 1. Distribution of ectasia in the coronary arteries. LM: left
main, LAD: left anterior descending artery, LCx: left circumflex
artery, RCA: right coronary artery.
Figure 2. Distribution of different types of coronary ectasia.Results
A total of 1115 coronary angiograms were
reviewed. Coronary artery ectasia was found in
67 patients (6% of all coronary angiograms). The
baseline characteristics and the biochemical pro-
files of the patients are shown in Table 1. The
mean age of our patients was 56 ± 12 years and
most patients were males, constituting 82% of
our sample. About 5% of our patients had history
of strokes; 57% had history of previous myocardial
infarction; 48% had previous history of angio-
plasty; 15% had history of coronary artery bypass
surgery; and no patient had history of connective
tissue disease. Fig. 1 shows that coronary artery
ectasia was seen more frequently in the right coro-
nary artery, which has ectasia in 73% of the cases,
while ectasia of the left main coronary artery was
seen in only 8% of the cases. Fig. 2 shows that sev-
ere coronary ectasia was seen in a significant por-
tion of our sample, 21% and 22% for coronary
ectasia type I and type II respectively, while local-
ized ectasia was seen in 42% of cases. Fig. 3 showsthat obstructive coronary artery disease was seen
in 66% of cases and slow flow in 61%. Regional
wall motion abnormalities on echocardiography
were seen in 54% of the cases. The mean ejection
fraction (EF) in class I was 55.7 ± 10.5%; in class II,
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and in class IV, it was 53.6 ± 15.8%, and there was
no statistically significant difference between the
classes (p value = 0.315). Table 2 summarizes the
medication patients were taking at the time of
the coronary angiogram. Table 3 shows the differ-
ences in patient characteristics between different
classes of ectasia.Discussion
Coronary artery ectasia is an uncommon disease
with controversies regarding its management. ToTable 3. Baseline characteristics of patients in different classes of c
Patient characteristics Class 1 Class 2
Age (years) 55 ± 8 59 ± 10
Sex (male %) 79% 80%
Nationality (Saudi %) 50% 53%
Diabetes mellitus 29% 71%
Hypertension 64% 73%
Dyslipidemia 50% 47%
Coronary artery disease 93% 100%
Smoking 30% 36%
Chronic renal failure 7% 13%
Table 2. Summary of patient medications.
Medication N = 67 (%)
Aspirin 97
Warfarin 8
Statins 95
Angiotensin converting enzyme inhibitors 59
Angiotensin receptor blockers 34
Nitroglycerin 49
Beta-blockers 91
Calcium channel blockers 22
Figure 3. Distribution of obstructive CAD and slow flow in the
sample. CAD: coronary artery disease.our knowledge, this is the first study to character-
ize coronary artery ectasia in a sample from Saudi
Arabia. In our sample, the incidence of coronary
artery ectasia among patients who underwent
invasive coronary angiography was slightly higher
(6%) than what has been published earlier. This
can be attributed to the increased prevalence of
atherosclerotic coronary artery disease in the
region, or the possibility of an increased genetic
susceptibility to the development of coronary
artery ectasia. This was suggested by the fact that
43% of our sample have a severe form of ectasia
(types I and II).
A previous meta-analysis showed that the
prevalence of diabetes mellitus in patients with
coronary artery ectasia was 8–33% and suggested
that diabetes might be a defense against the
development of coronary artery ectasia [13]. In
contrast, the prevalence of diabetes mellitus in
our sample was much higher at 59%. This can be
attributed to the fact that the prevalence of dia-
betes mellitus in the Saudi population is 23.7%,
which is considered one of the highest in the
world [14]. In addition, a higher prevalence of dia-
betes mellitus exists among Saudi patients with
coronary artery disease: one study has estimated
a prevalence of 58.1% in patients with acute coro-
nary syndrome in Saudi Arabia [15]. These con-
flicting results suggest the need for further
studies to evaluate the relationship between dia-
betes mellitus and coronary artery ectasia. Sixty-
one percent of our patients demonstrated slow-
flow phenomena, which usually indicates inade-
quate perfusion of the myocardium [16,17]. In
our study, 54% of the patients had wall motion
abnormalities on echocardiography, indicative of
myocardial ischemia or infarction. One study has
shown that coronary flow reserve was significantly
reduced in patients with coronary artery ectasia,
reflecting a microcirculatory dysfunction leading
to myocardial ischemia [18]. However, the clinical
importance of slow-flow phenomena in the con-
text of coronary artery ectasia is unknown andoronary ectasia.
Class 3 Class 4 P value
58 ± 11 55 ± 14 0.682
90% 82% 0.899
50% 57% 0.966
70 63% 0.075
60% 59% 0.827
80% 63% 0.332
100% 93% 0.590
33% 29% 0.974
20% 7% 0.678
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FROM SAUDI ARABIAneeds further evaluation. Several studies have
shown that the right coronary artery is the most
frequently involved artery with coronary ectasia
[7–9,19]. Seventy-three percent of our patients
had the right coronary artery involved. The rea-
sons for the higher right coronary artery predispo-
sition to ectasia are not well understood. Table 2
shows that 8% of our patients were taking war-
farin, prescribed for stroke prevention in atrial fib-
rillation. The role of anticoagulation in coronary
artery ectasia needs further evaluation.
Our study has some limitations including its
small sample size and being a single-center study.
As a retrospective study, it lacks information
about treatment and outcomes of the patients. In
conclusion, coronary artery ectasia has a higher
prevalence in Saudi Arabia among patients
undergoing invasive coronary angiography, and
patients tend to have diffuse disease. Further
studies are needed to investigate treatment mea-
sures and outcomes of coronary artery ectasia.References
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